Veterinary Pharmaceuticals/Biologics, Animal Feed, Pet Food & Animal Research

Food & Drug    Veterinary Pharmaceuticals/Biologics, Animal Feed, Pet Food & Animal Research
 

Food & Drug


Covington has the preeminent regulatory practice involving veterinary pharmaceuticals and biological products, animal feed, and pet food. Covington is the FDA regulatory counsel to most major animal health companies and to a number of companies that manufacture animal feeds or feed ingredients.  Our lawyers advise clients, both large and small, on all aspects of veterinary pharmaceutical and biologics regulation, manufacture, approval, and marketing.  We routinely advise feed and feed ingredient manufacturers on the complex, state-centric regulation of animal feeds, supplements, and pet food in the United States.  Our colleagues in our London and Brussels offices advise clients on the corresponding areas in Europe.  We also routinely defend companies in enforcement actions brought by FDA, USDA, and the states.  We also advise clients, including human pharmaceutical companies, on import and export issues for animal-based products and ingredients and on compliance with the Animal Welfare Act and its regulations governing animal research.  Covington’s animal food and drug practice dates back to the 1960s, and one of our senior lawyers specializing in this area holds a Doctorate of Veterinary Medicine (DVM) as well as a law degree.

Representative Matters

  • We have advised animal feed companies and trade associations regarding the new Food Safety Modernization Act, reportable food issues and the new FDA guidance on Salmonella in animal feed.
  • We assisted various companies with the import, compliance, and recall issues associated with the 2007 melamine contamination of pet food and its aftermath.
  • We have handled internal investigations for various clients and the related negotiations with agencies regarding the findings and underlying issues.
  • Our lawyers have advised animal drug manufacturers on FDA’s authority to regulate inactive ingredients in animal drugs in light of the Delaney “anticancer” Clause in the FDCA.
  • We assisted a client design, plan, and establish a significant new animal health business.
  • We have defended and successfully settled administrative compliance actions brought by the USDA under the Animal Welfare Act.
  • We successfully represented a coalition of companies in opposing release by a federal agency of sensitive information reflected in documents required to be filed with that agency.

Accolades

  • PLC Cross-border Super League
    • Ranked 1st in the Life Sciences Regulatory Super League (2004-2011)
    • Ranked 1st in the Life Sciences Industry Super League (2005-2009)
  • PLC - Life Sciences, Which Law Firm? (2011)
    • Leading: Regulatory firm, EU, USA, and England

Print PDF Word Version Print this page

Biographies
Publications

Contacts

elambert@cov.com
202.662.5422

gmasoudi@cov.com
202.662.5063

jperron@cov.com
202.662.5687